Protagonist Therapeutics, Inc. · NASDAQ:PTGX
Protagonist Therapeutics, Inc. shareholders
As of Jun 30, 2026, 333 institutions reported holding Protagonist Therapeutics, Inc. Largest: BlackRock, Vanguard and Farallon Capital Management, L.L.C. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Protagonist Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| BlackRock | 10.3M | +528K | Aug 7, 2026 | |
| Vanguard | 7.02M | +230K | Aug 13, 2026 | |
| Farallon Capital Management, L.L.C. | 6.35M | no change | Aug 14, 2026 | |
| Rtw Investments, LP | 5.06M | +2,122 | Aug 14, 2026 | |
| UBS | 3.51M | −1.78M | Aug 13, 2026 | |
| Wellington | 3.42M | −183K | Aug 14, 2026 | |
| State Street | 3.32M | +205K | Aug 7, 2026 | |
| Johnson & Johnson | 2.45M | no change | Aug 6, 2026 | |
| Invesco | 2.34M | +176K | Aug 14, 2026 | |
| T. Rowe Price | 2.15M | +484K | Aug 14, 2026 |